Glecaprevir

• Description:

  Glecaprevir (ABT 493; A 1282576) is a novel HCV NS3/4A protease inhibitor with pan-genotypic activity, inhibits NS3/4A proteases from HCV genotypes 1-6 in vitro with IC50 of 3.5-11.3 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  838.87

• Molecular Formula:

  C38H46F4N6O9S

• Notes:

  Research use only, not for human use.

• Receptor:

  HCVNS3/4Aprotease

• CAS Number:

  1365970-03-1